APPENDIX 11
Memorandum submitted by the Roy Castle
International Centre Lung Cancer Research
I enclose a statement relating to the difficulties
we are encountering in carrying out our research programme aimed
at the identification of people at high risk of developing lung
cancer and new methods of early detection of the disease. In the
main, these problems have arisen in the wake of the implementation
of the Caldicott Report, the Data protection act 1998 and the
GMC Guidelines.
We were fortunate recently to spend some time
with Dr Liam O'Toole, Director of the National Cancer Research
Institute when he visited the Roy Castle Centre for Lung Cancer
Research and discussed the aims and objectives and future vision
of the NCRI. He was very supportive of the early detection research
being undertaken here and we look forward to being involved in
future initiatives. We have strong collaboration with local clinicians
but as yet little involvement with the Merseyside and Cheshire
Cancer Network.
We look forward to the development of a stronger
collaborative research strategy between the NHS and academic institutions
to enable partnerships and facilitate research programmes for
the benefit of the health of our population. Such a collaborative
strategy is urgently required to break down some of the barriers
to for non-NHS organisations carrying out research within the
NHS environment.
We are all agreed that research into all aspects
of cancer remains a pressing need and hope that the means to achieve
our aims will become available in the near future.
Professor John Field
Director of Research
Dr Judith Youngson
Associate Director of Research
6 December 2001
| 
